Apollo-Excelcare Hospital

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes4 trials
• Obesity2 trials
• Chronic kidney disease1 trial
• High blood pressure1 trial

Phase

• Phase 33 trials
• Phase 42 trials

Status

• Completed4 trials
• Active, not recruiting1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• Novo Nordisk A/S2 trials
• Centre for Chronic Disease Control, India1 trial

Running trials

• Active, not recruiting

  A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity

  NCT07438444· Phase 4· Eli Lilly and Company· Source

Closed trials

• Completed

  A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

  NCT05803421· Phase 3· Eli Lilly and Company· Source

• Completed

  Treatment Optimisation for Blood Pressure With Single-Pill Combinations in India

  NCT05683301· Phase 4· Centre for Chronic Disease Control, India· Source

• Completed

  A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec

  NCT05352815· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes

  NCT03914326· Phase 3· Novo Nordisk A/S· Source